Green Cross Medical Science Corporation (142280) — Capital Reinvestment Ratio
Green Cross Medical Science Corporation (142280) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩5.01 Billion) in capital expenditures (₩460.89 Million). Check tangible net worth ratio of Green Cross Medical Science Corporation to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Green Cross Medical Science Corporation Capital Reinvestment Ratio (2016–2025)
This chart tracks Green Cross Medical Science Corporation's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Green Cross Medical Science Corporation (142280) cash conversion ratio.
Annual Capital Reinvestment Ratio for Green Cross Medical Science Corporation (2016–2025)
Year-by-year Capital Reinvestment Ratio for Green Cross Medical Science Corporation from 2016 to 2025. See 142280 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | ₩7.20 Billion | ₩4.90 Billion | ▼ -22.5% |
| 2024 | 0.88x | ₩3.66 Billion | ₩3.22 Billion | ▼ -33.9% |
| 2023 | 1.33x | ₩4.24 Billion | ₩5.63 Billion | ▲ +321.7% |
| 2022 | 0.31x | ₩10.88 Billion | ₩3.43 Billion | ▼ -11.4% |
| 2017 | 0.36x | ₩3.11 Billion | ₩1.11 Billion | ▲ +93.2% |
| 2016 | 0.18x | ₩10.25 Billion | ₩1.89 Billion | — |